2021 EAN/PNS Guideline on Diagnosis and Treatment of CIDP
an open access webinar sponsored by the Peripheral Nerve Society
Wednesday, 27 October 2021
08.00 PDT • 10.00 CDT • 11.00 EDT • 16.00 BST • 17.00 CEST • 12.00 (28 Oct.) JST • 02.00 (28 Oct.) AEDT
This new EAN/PNS CIDP guideline is a long awaited revision of the 2010 EFNS/PNS CIDP guideline. CIDP is a container term for a number of heterogeneous neuropathies, including typical CIDP and CIDP variants. Misdiagnosis is common and mainly occurs in CIDP variants. Therefore, redefining and refining clinical and electrodiagnostic criteria for CIDP variants is a top priority and will be discussed. How possible CIDP or CIDP can be diagnosed based on the strength of the electrodiagnostic evidence supportive of demyelination and upon fulfilment of supportive criteria (imaging, CSF, response to treatment or nerve biopsy) will be discussed. In the diagnostic strategy, much attention is paid to differential diagnosis. Treatment is recommended only if there is disability and impairment and if there is active disease. Recommendations for induction and maintenance treatment will be presented.
Peter Van den Bergh, MD, PhD, FEAN, FAAN, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Peter Van den Bergh is Full Professor of Neurology (emeritus) at the University of Louvain, Brussels, Belgium. Fascinated by neuromuscular diseases, he obtained a grant from the ALS Foundation USA to do research on ALS and muscle pathology at USC Good Samaritan Hospital in Los Angeles and at Tufts New England Medical Center in Boston. He is certified by the Board of the AANEM. In 1999, he creates the UCL Saint-Luc Neuromuscular Reference Center and received the Center of Excellence label from the GBS/CIDP Foundation International. He is a member of Euro-NMD and co-chairs the Euro-NMD neurophysiology group. His main areas of research are inflammatory neuropathies, electrodiagnosis and functional assessment scales in neuromuscular patients. He is the author of more than 185 peer-reviewed publications. He is immediate past-chair of the Inflammatory Neuropathy Consortium (INC).
Richard Lewis, MD
Cedars-Sinai Medical Center
Los Angeles, CA, USA
Pieter van Doorn, MD, PhD
Erasmus MC University Medical Center
Rob Hadden, PhD, FRCP, BM, BCh
King's College Hospital
What does my registration include? Full access to the 2021 EAN/PNS CIDP Guideline on Diagnosis and Treatment of CIDP webinar on 27 October 2021. PNS members will have access to the recorded content in the On-Demand Education Center post-event.
Questions? If you experience technical difficulties or need assistance during the registration process, please contact the PNS Executive Office at info@PNSociety.com.
Event Modification or Cancellation
PNS reserves the right to modify the event schedule or program as necessary. PNS also reserves the right to cancel this event.
If you are a member and register for the event, we will access the information in your member account to provide you with information and services associated with the event. If you are not a member and you register for the event, we will collect your name and contact information, which we will store in our database and used to provide you with information and services associated with the event. If you are a presenter at the event, we will collect information about you including your name, employer and contact information, and photograph, and we may also collect information provided by event attendees who evaluated your performance as a presenter. As an attendee, speaker, or sponsor/exhibitor, we will keep a record of your participation to provide you with post-event information including details on upcoming events you may be interested in. If you do not opt out in the registration process, your contact information may be shared via an event attendee list as part of your participation at the meeting.